info@flamel.com
 
Management and Boards
Strategy and Alliances
Research and Development
Manufacturing
Job Opportunities
Standards of Business Conduct
Code of Ethics
Strategy and Alliances
Flamel's Strategy

By combining the Company's established pre-clinical, clinical and regulatory expertise with the capability to formulate and manufacture drugs, Flamel is turning already-marketed or new drugs into more effective and safer medicines for itself and for its partners.

The Company’s business model is to leverage its proprietary technology platforms through partnership agreements. This approach is a highly efficient way to develop a diversified portfolio of product opportunities while benefiting from the partner companies' comparative advantage in areas such as clinical development and regulatory affairs, as well as sales and marketing.

Flamel's Alliances

Flamel Technologies has currently partnerships with the following companies :

Company Product/Description Indications Technology Status
Blood clotting factors Hemophilia MEDUSA Undisclosed
COREG CR Cardiovascular diseases MICROPUMP Launched
Undisclosed Marketed Protein Undisclosed MEDUSA Undisclosed
Undisclosed Undisclosed Undisclosed Undisclosed
Undisclosed Marketed Protein Undisclosed MEDUSA Undisclosed


Flamel has other undisclosed partnerships.